Eli Lilly Files 8-K on Shareholder Vote Matters

Ticker: LLY · Form: 8-K · Filed: 2024-05-09T00:00:00.000Z

Sentiment: neutral

Topics: governance, shareholder-vote

Related Tickers: LLY

TL;DR

LLY filed an 8-K for shareholder vote matters - expect updates on governance.

AI Summary

Eli Lilly and Company (LLY) filed an 8-K on May 9, 2024, to report the submission of matters to a vote of security holders. This filing indicates that the company is preparing for or has held a shareholder meeting where important company decisions are being voted upon. Specific details regarding the proposals or outcomes of the vote were not included in this particular filing, but it serves as a formal notification to the SEC and investors.

Why It Matters

This filing signals that Eli Lilly is engaging in corporate governance processes, which can impact shareholder rights and company direction.

Risk Assessment

Risk Level: low — This filing is a procedural notification and does not contain new financial or operational risks.

Key Players & Entities

FAQ

What specific matters were submitted for a vote of security holders?

The filing does not specify the exact matters submitted for a vote, only that such matters were presented.

When did the submission of matters to a vote of security holders occur?

The filing was made as of May 9, 2024, and the period of report was May 6, 2024, indicating the matters were submitted around this time.

Is this filing related to a specific event like an acquisition or earnings release?

No, this 8-K filing specifically pertains to the 'Submission of Matters to a Vote of Security Holders' and not other typical 8-K event types.

Does this filing provide details on the outcome of the shareholder vote?

No, this filing serves as notification of the submission of matters to a vote, not the results or outcomes of that vote.

What is the SEC Act under which this report is filed?

This report is filed pursuant to the 1934 Act.

From the Filing

0000059478-24-000127.txt : 20240509 0000059478-24-000127.hdr.sgml : 20240509 20240509163408 ACCESSION NUMBER: 0000059478-24-000127 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240506 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 24931328 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 8-K 1 lly-20240506.htm 8-K lly-20240506 0000059478 false 0000059478 2024-05-06 2024-05-06 0000059478 us-gaap:CommonClassAMember 2024-05-06 2024-05-06 0000059478 lly:A718NotesDueJune12025Member 2024-05-06 2024-05-06 0000059478 lly:A1.625NotesDueJune22026Member 2024-05-06 2024-05-06 0000059478 lly:A2.125NotesDueJune32030Member 2024-05-06 2024-05-06 0000059478 lly:A625Notesdue2031Member 2024-05-06 2024-05-06 0000059478 lly:A500NotesDue2033Member 2024-05-06 2024-05-06 0000059478 lly:A6.77NotesDueJanuary12036Member 2024-05-06 2024-05-06 0000059478 lly:A1625NotesDue2043Member 2024-05-06 2024-05-06 0000059478 lly:A1.700Notesdue2049Member 2024-05-06 2024-05-06 0000059478 lly:A1125NotesDue2051Member 2024-05-06 2024-05-06 0000059478 lly:A1375NotesDue2061Member 2024-05-06 2024-05-06   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 6, 2024 ELI LILLY AND COMPANY (Exact Name of Registrant as Specified in its Charter)   Indiana   001-06351   35-0470950 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)     Lilly Corporate Center Indianapolis, Indiana 46285 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: ( 317 ) 276-2000 Not Applicable (Former Name or Former Address, if Changed Since Last Report.)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2.): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock (no par value) LLY New York Stock Exchange 7 1/8% Notes due 2025 LLY25 New York Stock Exchange 1.625% Notes due 2026 LLY26 New York Stock Exchange 2.125% Notes due 2030 LLY30 New York Stock Exchange 0.625% Notes due 2031 LLY31 New York Stock Exchange 0.500% Notes due 2033 LLY33 New York Stock Exchange 6.77% Notes due 2036 LLY36 New York Stock Exchange 1.625% Notes due 2043 LLY43 New York Stock Exchange 1.700% Notes due 2049 LLY49A New York Stock Exchange 1.125% Notes due 2051 LLY51 New York Stock Exchange 1.375% Notes due 2061 LLY61 New York Stock Exchange Indicate by check mark whether the registrant is an emerging

View on Read The Filing